Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bartkova

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
The Journal of Pathology|June 2, 2006
Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpressionM K Koutsami, P K Tsantoulis, M Kouloukoussa, et al.
Oncogene|November 6, 2007
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancerJ Tommiska, J Bartkova, M Heinonen, et al.
Oncogene|August 29, 2012
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage responseT Schepeler, P Lamy, V Hvidberg, et al.
Cell Death and Differentiation|July 16, 2013
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesisK Evangelou, J Bartkova, A Kotsinas, et al.
Oncogene|March 3, 2015
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repairN Kanu, E Grönroos, P Martinez, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
The Journal of Pathology|June 2, 2006
Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpressionM K Koutsami, P K Tsantoulis, M Kouloukoussa, et al.
Oncogene|November 6, 2007
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancerJ Tommiska, J Bartkova, M Heinonen, et al.
Oncogene|August 29, 2012
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage responseT Schepeler, P Lamy, V Hvidberg, et al.
Cell Death and Differentiation|July 16, 2013
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesisK Evangelou, J Bartkova, A Kotsinas, et al.
Oncogene|March 3, 2015
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repairN Kanu, E Grönroos, P Martinez, et al.
Pageof 7